证券时报e公司讯,今天,晶泰科技宣布与新加坡国立癌症中心(National Cancer Centre Singapore,NCCS)以及杜克-新加坡国立大学医学院(Duke-NUS Medical School, Duke-NUS)开展 AI 新药发现合作,晶泰科技将运用其 AI 和自动化实验驱动的多肽研发设计平台,针对 NCCS 选定的肾透明细胞癌(Clear Cell Renal Cell ...
TLX250-CDx is an investigational PET 3 drug product for the non-invasive diagnosis and characterization of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer ...
Relevance section written by JCO Clinical Cancer Informatics Associate Editor Ziad Bakouny, MD, MSc. The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model was ...